Chandra Saravanan

Company: Novartis

Job title: Director - Pathology

Bio:

Chandra Saravanan is a board-certified Veterinary Pathologist working at Novartis Biomedical Research, Cambridge, MA. At Novartis, he supports investigative and regulatory toxicological studies for the pipeline projects. Prior to this position, he was a Novartis Presidential Postdoctoral Fellow. Dr. Saravanan completed his residency in Veterinary Anatomic Pathology at the Tufts University, North Grafton, MA after earning his PhD in Cell, Molecular and Developmental Biology from Tufts University, Boston, MA. His research interests are to investigate disease mechanisms using conventional and advanced molecular pathology tools.

Seminars:

Underpinning the Transformative Potential of Spatial Omics in Toxicologic Pathology 4:45 pm

Considering the preanalytical variables that can influence the quality and reproducibility of spatial omics data Exploring how spatial omics can be applied effectively in preclinical species to generate meaningful insights Highlighting the vital role of pathologists in designing, conducting, and interpreting spatial omics experimentsRead more

day: Day One